Search

everythinglearnresearchcommunity

for

Search:↓

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Aromatase gene variation may increase female hair loss risk.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Early hair loss may indicate risk of insulin resistance.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgens prevent hair growth by changing Wnt signals in cells.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.